Intrinsic and Effective Severity of Coronavirus Disease 2019 Cases Infected With the Ancestral Strain and Omicron BA.2 Variant in Hong Kong
The Journal of Infectious Diseases · 2023
DOI: 10.1093/infdis/jiad236 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Jessica Y Wong und 7 weiteren Autor:innen. Beteiligte Einrichtung: World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medic…. Hauptthemen laut MEDLINE: COVID-19, Epidemics. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Health and Medical Research Fund, Hong Kong Special Administrative Region (SAR) government, Collaborative Research Scheme.
Abstract (Originalsprache)
Background
Understanding severity of infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants is crucial to inform public health measures. Here we used coronavirus disease 2019 (COVID-19) patient data from Hong Kong to characterize the severity profile of COVID-19.
Methods
Time-varying and age-specific effective severity measured by case hospitalization risk and hospitalization fatality risk was estimated with all individual COVID-19 case data collected in Hong Kong from 23 January 2020 through 26 October 2022 over 6 epidemic waves. The intrinsic severity of Omicron BA.2 was compared with the estimate for the ancestral strain with the data from unvaccinated patients without previous infections.
Results
With 32 222 COVID-19 hospitalizations and 9669 deaths confirmed over 6 epidemic waves, the time-varying hospitalization fatality risk dramatically increased from <10% before the largest fifth wave of Omicron BA.2 to 41% during the peak of the fifth wave when hospital resources were severely constrained. The age-specific fatality risk in unvaccinated hospitalized Omicron cases was comparable to the estimates for unvaccinated cases with the ancestral strain. During epidemics predominated by Omicron BA.2, fatality risk was highest among older unvaccinated patients.
Conclusions
Omicron has comparable intrinsic severity to the ancestral Wuhan strain, although the effective severity is substantially lower in Omicron cases due to vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Reg…
- Laboratory of Data Discovery for Health Limited, Hong Kong Science and Technology Park, New Territories, Hong Kong Special Administrative Region, China.
ORCID-Profile: Jessica Y Wong, Benjamin J Cowling, Peng Wu
Förderung
- Health and Medical Research Fund
- Hong Kong Special Administrative Region (SAR) government
- Collaborative Research Scheme
- Research Grants Council
- Hong Kong SAR government
- RGC Senior Research Fellow Scheme
- Hong Kong SAR
Zitieren
APA
Wong, J. Y., Cheung, J. K., Lin, Y., Bond, H. S., Lau, E. H. Y., Ip, D. K. M., Cowling, B. J., & Wu, P. (2023). Intrinsic and Effective Severity of Coronavirus Disease 2019 Cases Infected With the Ancestral Strain and Omicron BA.2 Variant in Hong Kong. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad236
Vancouver
Wong JY, Cheung JK, Lin Y, Bond HS, Lau EHY, Ip DKM, et al. Intrinsic and Effective Severity of Coronavirus Disease 2019 Cases Infected With the Ancestral Strain and Omicron BA.2 Variant in Hong Kong. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiad236
BibTeX
@article{Wong2023,
author = {Wong, Jessica Y and Cheung, Justin K and Lin, Yun and Bond, Helen S and Lau, Eric H Y and Ip, Dennis K M and Cowling, Benjamin J and Wu, Peng},
title = {Intrinsic and Effective Severity of Coronavirus Disease 2019 Cases Infected With the Ancestral Strain and Omicron BA.2 Variant in Hong Kong},
journal = {The Journal of Infectious Diseases},
year = {2023},
doi = {10.1093/infdis/jiad236}
}
EUVIMED